An investigation of the role of intraluminal proteolytic enzymes and intracellular enzyme inhibitors in ulcerative colitis.
D000293:Adolescent; D000328:Adult; D002918:Chymotrypsin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000201:enzymology* / Q000209:etiology / Q000601:surgery; D003106:Colon / Q000201:enzymology*; D003110:Colonic Neoplasms / Q000201:enzymology / Q000601:surgery; D005260:Female; D006471:Gastrointestinal Hemorrhage; D006801:Humans; D007081:Ileostomy; D007413:Intestinal Mucosa / Q000201:enzymology; D007417:Intestinal Polyps / Q000201:enzymology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000201:enzymology; D011480:Protease Inhibitors; D012636:Secretory Rate; D014357:Trypsin / Q000378:metabolism*; D014361:Trypsin Inhibitors / Q000032:analysis
D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D002918:Chymotrypsin; D014357:Trypsin